Biotech

All Articles

Viridian eye health condition phase 3 smash hits, accelerating push to competing Amgen

.Viridian Therapies' phase 3 thyroid eye ailment (TED) professional test has actually struck its own...

Bain unveils $3B fund for life scientific research providers

.Along with a strong track record for identifying diamonds in the rough, Bain Resources Everyday Lif...

Genentech's cancer restructure brought in 'for scientific reasons'

.The latest decision to merge Genentech's 2 cancer cells divisions was actually made for "medical ex...

Tern oral GLP-1 shows 5% fat loss at 1 month at highest possible dose

.Terns Pharmaceuticals' choice to lose its liver illness ambitions might yet pay off, after the biot...

Merck, Daiichi loyal very early success in tiny tissue lung cancer cells with updated ADC records

.Merck &amp Co.'s long-running initiative to land a blow on little cell lung cancer cells (SCLC) has...

Boehringer, Bayer innovation lung cancer cells medicines towards Astra war

.Some clients with non-small tissue bronchi cancer cells (NSCLC) have anomalies in a gene called hum...

MBX pursues $136M IPO to take competitor to Ascendis right into period 3

.MBX has elaborated strategies to enjoy over $136 thousand coming from its IPO as the biotech aims t...

Relay breast cancer data tee up clash with AstraZeneca's Truqap

.Relay Rehabs has actually hammered its own survival objective in a first-in-human boob cancer cells...

AZ lays out AI-enabled TROP2 biomarker tactic for Daiichi ADC

.AstraZeneca has actually used expert system to create an one-of-a-kind biomarker for its own Daiich...

AstraZeneca IL-33 drug falls short to boost COPD breathing in ph. 2

.AstraZeneca execs mention they are "not stressed" that the breakdown of tozorakimab in a phase 2 se...